The Impact of Lung Function on Extra-Pulmonary Diseases and All-Cause Mortality in US Adult Population with and without COPD

References

• Petousi N, Talbot NP, Pavord I, Robbins PA. Measuring lung function in airways diseases: current and emerging techniques. Thorax. 2019;74(8):797–805. doi:10.1136/thoraxjnl-2018-21244131036773
   PubMed Web of Science ®Google Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST31613151
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
   PubMed Web of Science ®Google Scholar
• Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther. 2019;198:160–188. doi:10.1016/jharmthera.2019.02.01330822464
   PubMed Web of Science ®Google Scholar
• Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis. 2016;68(3):414–421. doi:10.1053/jjkd.2016.03.41527130720
   PubMed Web of Science ®Google Scholar
• Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;70(2):128–134. doi:10.1016/jjcc.2017.03.00128325523
   PubMed Web of Science ®Google Scholar
• Gershon A, Hwee J, Victor JC, et al. Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012. Thorax. 2015;70(2):121–126. doi:10.1136/thoraxjnl-2014-20595625428609
   PubMed Web of Science ®Google Scholar
• Gershon AS, Thiruchelvam D, Chapman KR, et al. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153(6):1336–1346. doi:10.1016/jhest.2018.01.03829425675
   PubMed Web of Science ®Google Scholar
• Chai C-S, Liam C-K, Pang Y-K, et al. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:565–573. doi:10.2147/COPD19610930880946
   PubMed Web of Science ®Google Scholar
• Lee H, Shin SH, Gu S, et al. Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease. BMC Med. 2018;16(1):178. doi:10.1186/s12916-018-1159-730285854
   PubMed Web of Science ®Google Scholar
• Jo YS, Choi SM, Lee J, et al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010–2012. Respir Med. 2015;109(1):96–104. doi:10.1016/jmed.2014.10.01525434653
   PubMed Web of Science ®Google Scholar
• Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99. doi:10.2147/COPD2748022371650
   PubMed Web of Science ®Google Scholar
• Nathell L, Nathell M, Malmberg P, Larsson K. COPD diagnosis related to different guidelines and spirometry techniques. Respir Res. 2007;8(1):89. doi:10.1186/1465-9921-8-8918053200
   PubMed Web of Science ®Google Scholar
• Hall GL, Irvin CG. Using lung function measurements to greater advantage in patients with lung disease: which test and when? Respirology (Carlton, Vic). 2014;19(6):780–781. doi:10.1111/resp.12331
   Web of Science ®Google Scholar
• Kodal JB, Kobylecki CJ, Vedel-Krogh S, Nordestgaard BG, Bojesen SE. AHRR hypomethylation, lung function, lung function decline and respiratory symptoms. Eur Respir J. 2018;51(3):3. doi:10.1183/13993003.01512-2017
   Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.97121089872837
   PubMed Web of Science ®Google Scholar
• Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019;73(23):3018–3026. doi:10.1016/jacc.2019.03.50731196460
   PubMed Web of Science ®Google Scholar
• Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S00229222373
   PubMed Web of Science ®Google Scholar
• Ward ZJ, Bleich SN, Cradock AL, et al. Projected US state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–2450. doi:10.1056/NEJMsa190930131851800
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.19264419805654
   PubMed Web of Science ®Google Scholar
• Park HJ, Leem AY, Lee SH, et al. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis. 2015;10:1571–1582. doi:10.2147/COPD8576726300636
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-0000619414839
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-0000723732715
   PubMed Web of Science ®Google Scholar
• Looker AC. Femur neck bone mineral density and fracture risk by age, sex, and race or Hispanic origin in older US adults from NHANES III. Arch Osteoporos. 2013;8:141. doi:10.1007/s11657-013-0141-4
   Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9 validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.01600960611556941
   PubMed Web of Science ®Google Scholar
• Raherison C, Ouaalaya EH, Bernady A, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulm Med. 2018;18(1):117. doi:10.1186/s12890-018-0684-730012144
   PubMed Web of Science ®Google Scholar
• Chen WL, Wang CC, Wu LW, et al. Relationship between lung function and metabolic syndrome. PLoS One. 2014;9(10):e108989. doi:10.1371/journalone.010898925299452
   PubMed Web of Science ®Google Scholar
• Ford ES, Cunningham TJ, Mercado CI. Lung function and metabolic syndrome: findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes. 2014;6(6):603–613. doi:10.1111/1753-0407.1213626677470
   PubMed Web of Science ®Google Scholar
• Wheaton AG, Ford ES, Thompson WW, Greenlund KJ, Presley-Cantrell LR, Croft JB. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States–National Health and Nutrition Examination Survey 2007–2010. BMC Public Health. 2013;13(1):854. doi:10.1186/1471-2458-13-85424040892
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212. doi:10.1183/09031936.0011430718166598
   PubMed Web of Science ®Google Scholar
• Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology (Carlton, Vic). 2011;16(8):1165–1172. doi:10.1111/j.1440-1843.2011.02062
   PubMed Web of Science ®Google Scholar
• Niles AN, O’Donovan A. Comparing anxiety and depression to obesity and smoking as predictors of major medical illnesses and somatic symptoms. Health Psychol. 2019;38(2):172–181. doi:10.1037/hea000070730556708
   PubMed Web of Science ®Google Scholar
• Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199–208. doi:10.2147/COPD1061121660297
   PubMed Web of Science ®Google Scholar
• Agustí AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367–370; discussion 371-362. doi:10.1513/pats.200504-026SR
   Google Scholar
• Tuder RM, Yun JH, Bhunia A, Fijalkowska I. Hypoxia and chronic lung disease. J Mol Med (Berl). 2007;85(12):1317–1324. doi:10.1007/s00109-007-0280-418040654
   PubMed Web of Science ®Google Scholar